Clinical Trial: Study of YKYY032 Injection in Adults With Hyperlipoproteinemia (a)

U.S., Nov. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07914660) titled 'Study of YKYY032 Injection in Adults With Hyperlipoproteinemia (a)' on Oct. 19.

Brief Summary: Phase II clinical trial to evaluate the efficacy and safety of YKYY032 injection in adults with hyperlipoproteinemia (a)

Study Start Date: Nov. 20

Study Type: INTERVENTIONAL

Condition: Hyperlipoproteinemia (a)

Intervention: DRUG: YKYY032 group

Drug: YKYY032 Injection Subcutaneous administration of YKYY032 on Day 1 and Day 180 (2 doses, approximately 6 months apart)

OTHER: YKYY032 Placebo group

Drug: YKYY032 Placebo Subcutaneous administration of matching placebo on Day 1 and Day 180 (2 doses, approximately 6 months apart)

Recruitm...